United States News Todas as matérias

Central Pacific Financial (NYSE:CPF) generated $20.8 million in net income during the second quarter of 2026 following higher average balances and yields.

Gorman-Rupp (NYSE:GRC) generated $186.1 million in net sales for the second quarter following increased industrial demand.

Gilead Sciences (NASDAQ:GILD) received CHMP backing for Trodelvy plus Keytruda after the regimen reduced progression or death risk by 35%.

Flagstar Bank (NYSE:FLG) reported second-quarter net income of $34 million, marking its third consecutive profitable quarter.

Southside Bancshares (NYSE:SBSI) reported second-quarter net income of $26.8 million, up 23%, as revenue increased and expenses declined.

Salesforce (NYSE:CRM) was awarded, through its distribution network, a VA software agreement with a $1.6 billion three-year ceiling.

Brent crude reached $100.30 per barrel as disruptions threatened oil flows through the Strait of Hormuz and Red Sea.

Wise (NASDAQ:WSE) shares fell 10% after U.S. regulators denied its national trust bank application for direct Federal Reserve access.

MannKind (NASDAQ:MNKD) received FDA approval for Furoscix ReadyFlow, an 80 mg/mL autoinjector treating edema in adults with heart or kidney disease.

The US administration has imposed a 12.5% import tariff on Australian products following a Section 301 trade investigation.

Albertsons (NYSE:ACI) reported first-quarter fiscal 2026 adjusted EPS of $0.42, missing $0.54 estimates and triggering a sharp share sell-off.

Nasdaq (NASDAQ:NDAQ) reported second-quarter net revenue of $1.5 billion, up 15%, as each of its three operating divisions recorded growth.

NVR (NYSE:NVR) reported its second-quarter 2026 financial results, generating $2.33 billion in consolidated revenues, a decline from the $2.60 billion reported in the same period last year.

Norfolk Southern (NYSE:NSC) reported its second-quarter 2026 financial results, generating an all-time quarterly record of $3.5 billion in revenue.

Mobileye Global (NASDAQ:MBLY) reported second-quarter revenue of $508 million as higher system shipments offset lower average selling prices.

Eli Lilly (NYSE:LLY) announced positive topline Phase 3 results for its investigational triple agonist, retatrutide, from the 80-week TRIUMPH-2 and TRIUMPH-3 clinical trials.

Thermo Fisher Scientific (NYSE:TMO) reported second-quarter revenue of $11.99 billion, up 10%, as customer activity strengthened across its markets.

Bread Financial (NYSE:BFH) reported its second-quarter 2026 financial results, generating $993 million in revenue.

Lazard (NYSE:LAZ) reported second-quarter net revenue of $808 million, up 1%, while adjusted net revenue increased 2% to $786 million.

Quest Diagnostics (NYSE:DGX) reported second-quarter revenue of $3.04 billion, up 10.2%, as diagnostic-testing volumes increased across its customer channels.

MarineMax (NYSE:HZO) reported fiscal third-quarter revenue of $611.3 million, down 7%, despite higher gross profit and wider margins.

Ermenegildo Zegna Group (NYSE:ZGN) reported second-quarter revenue of €517.1 million, up 10.3%, as all three fashion brands recorded organic growth.

Snap-on (NYSE:SNA) reported second-quarter sales of $1.24 billion, up 4.7%, while diluted EPS increased to $4.96.

Visteon (NASDAQ:VC) reported second-quarter sales of $960 million, with net income of $49 million and diluted EPS of $1.80.